Background: Clinical research on moyamoya disease (MMD) has focused on symptomatic outcome such as transient ischemic attacks. Neurocognitive function in children critically affects social outcome and is closely related to quality of life. This study is the first to analyze the neurocognitive profiles of children with MMD before and after surgery. Methods: Sixty-five patients were selected out of 137 who underwent surgery for MMD between 2006 and 2008. The preoperative and postoperative neurocognitive function was tested using the Korean version of the Wechsler Intelligence Scale for Children-Revised (KEDI-WISC-R) and the Bender Gestalt Test (BGT). Pre- and postoperative profiles of patients with or without major infarctions were compared. Patients with borderzone infarctions were analyzed as well. Results: Preoperatively, patients had age-appropriate full-scale intelligence quotient (FSIQ) and verbal IQ (VIQ) scores, which were maintained after surgery. There was significant improvement in performance IQ (PIQ) (p = 0.01) and BGT scores postoperatively (p < 0.01). Among the subtests, Coding showed significant improvement postoperatively (p < 0.01). Preoperatively, patients with major infarctions had significantly lower FSIQ (p < 0.01), VIQ (p = 0.01) and PIQ (p < 0.01) scores compared with those without infarctions. The pre- and postoperative neurocognitive profiles of the patients with borderzone infarctions fell between those of patients with absolutely no infarctions and those of patients with major infarctions. Conclusions: Considering the natural history of MMD, which leads to a drastic decline in neurocognitive functions, the present findings indicate a role for early active surgery to save the intellectual abilities of children with MMD.

Keywords:
Moyamoya disease, Neurocognitive profile, Children
1.
Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG: Classification of stroke subtypes. Cerebrovasc Dis 2009;27:493–501.
2.
Matsushima Y, Aoyagi M, Masaoka H, Suzuki R, Ohno K: Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age. Childs Nerv Syst 1990;6:440–443.
3.
Fukuyama Y, Umezu R: Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis (‘moyamoya’ disease) in children. Brain Dev 1985;7:21–37.
4.
Isono M, Ishii K, Kamida T, Inoue R, Fujiki M, Kobayashi H: Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis. Pediatr Neurosurg 2002;36:14–21.
5.
Lee M, Zaharchuk G, Guzman R, Achrol A, Bell-Stephens T, Steinberg GK: Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus 2009;26:E5.
6.
Huang AP, Liu HM, Lai DM, Yang CC, Tsai YH, Wang KC, Yang SH, Kuo MF, Tu YK: Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease. Cerebrovasc Dis 2009;28:247–257.
7.
Bornstein RA: Neuropsychological performance in moyamoya disease: a case study. Int J Neurosci 1985;26:39–46.
8.
Imaizumi C, Imaizumi T, Osawa M, Fukuyama Y, Takeshita M: Serial intelligence test scores in pediatric moyamoya disease. Neuropediatrics 1999;30:294–299.
9.
Ishii R, Takeuchi S, Ibayashi K, Tanaka R: Intelligence in children with moyamoya disease: evaluation after surgical treatments with special reference to changes in cerebral blood flow. Stroke 1984;15:873–877.
10.
Karzmark P, Zeifert PD, Tan S, Dorfman LJ, Bell-Stephens TE, Steinberg GK: Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery 2008;62:1048–1051;discussion 1051–1052.
11.
Kuroda S, Houkin K, Ishikawa T, Nakayama N, Ikeda J, Ishii N, Kamiyama H, Iwasaki Y: Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis. Childs Nerv Syst 2004;20:302–308.
12.
Ohtaki M, Uede T, Morimoto S, Nonaka T, Tanabe S, Hashi K: Intellectual functions and regional cerebral haemodynamics after extensive omental transplantation spread over both frontal lobes in childhood moyamoya disease. Acta Neurochir (Wien) 1998;140:1043–1053;discussion 1052–1053.
13.
Kim SK, Wang KC, Kim IO, Lee DS, Cho BK: Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease. Neurosurgery 2002;50:88–96.
14.
Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC: Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 2010;68:92–101.
15.
Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K: Surgical treatment of moyamoya disease in pediatric patients – comparison between the results of indirect and direct revascularization procedures. Neurosurgery 1992;31:401–405.
16.
Park K, Yoon J, Park H (eds): The Manual of Korean Educational Development Institute-Wechsler Intelligence Scale for Children-Revised. Seoul, Korean Educational Development Institute, 1991.
17.
Bender L: A Visual Motor Gestalt Test and Its Clinical Use. New York, American Orthopsychiatric Association, 1938.
18.
Imaizumi T, Hayashi K, Saito K, Osawa M, Fukuyama Y: Long-term outcomes of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol 1998;18:321–325.
19.
Kurokawa T, Tomita S, Ueda K, Narazaki O, Hanai T, Hasuo K, Matsushima T, Kitamura K: Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol 1985;1:274–277.
20.
Sato H, Sato N, Tamaki N, Matsumoto S: Chronic low-perfusion state in children with moyamoya disease following revascularization. Childs Nerv Syst 1990;6:166–171.
21.
Wechsler D: Wechsler Intelligence Scale for Children-Revised Manual. New York, Psychological Corporation, 1974.
22.
Matsushima Y, Aoyagi M, Nariai T, Takada Y, Hirakawa K: Long-term intelligence outcome of post-encephalo-duro-arterio-synangiosis childhood moyamoya patients. Clin Neurol Neurosurg 1997;99(suppl 2):S147–S150.
23.
Bornstein RA: Verbal IQ-performance IQ discrepancies on the Wechsler Adult Intelligence Scale-Revised in patients with unilateral or bilateral cerebral dysfunction. J Consult Clin Psychol 1983;51:779–780.
24.
Iverson GL, Mendrek A, Adams RL: The persistent belief that VIQ-PIQ splits suggest lateralized brain damage. Appl Neuropsychol 2004;11:85–90.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.